Introduction
Properly organised brain banks have a relatively recent history with only a few more than a decade old.' Much recent progress in the understanding of the pathogenesis of both common and rare disorders of the nervous system has come about by the use of postmortem human brain tissue. This scientific progress has been based on the systematic collection and distribution by brain banks of brain tissue according to standardised clinical and pathological criteria. In order to be responsive to technological and scientific advances in medical research brain banks need to be located in centres with a strong academic and neuroscience base. Where material from rare familial cases or childhood disorders is scarce, cooperation with other brain banks may be necessary. Brain banks need to have policies for allocating rare and invaluable material as well as considering safety and ethical issues surrounding the use of donated human tissue for medical research. To be successful, brain banks need to liaise effectively and sensitively with a large constituency of 
Clinical information
The detailed clinical assessment of patients is an important prerequisite of brain banking and an essential component of any clinicopathological study. Users of tissue need confidence that the patient has been assessed and diagnosed in a reliable and systematic manner. A sound clinical diagnosis is particularly important with psychiatric patients, such as those with schizophrenia where the neuropathology, given the current state of knowledge, may be subtle. In a typical area based study, patients will be regularly assessed, ideally at least annually, until death. The clinician, in consultation with the brain bank, will seek permission from the patient or his or her family for a postmortem examination and removal of brain tissue and other organs for medical research. Ideally, standardised biochemical, medical, psychiatric, and neurological examinations will be carried out by experienced clinicians. Imaging (computed tomography, magnetic resonance imaging, functional magnetic resonance imaging, and positron emission tomography) may be performed if there are local facilities.
Pathological protocols Brain tissue obtained either at biopsy or necropsy should be examined by a neuropathologist. This neuropathological assessment has two functions. Firstly, it is a means of validating the clinical diagnosis, arguably the most reliable audit of clinical diagnosis and treatment, and, secondly, it is a form of quality control of tissue provided to the neuroscience community.'°Making a neuropathological diagnosis is not always straightforward. Not uncommonly, the diagnosis, particularly with neurodegenerative disorders, depends on the estimation of the severity or density of a particular lesion, such as the numbers of neuritic plaques in Alzheimer's disease, and comparing this "pathological" density with "age related" changes. In addition, the diagnosis may be complicated by being dependent on the clinical diagnosis. For where additional pathology is revealed during the macroscopic examination of the brain, additional blocks of tissue may be taken to make a sound diagnosis. Clearly, the sampling of tissue will be influenced by the clinical diagnosis. While samples of the spinal cord will be necessary to confirm a diagnosis of motor neurone disease, the diagnosis of Alzheimer's disease can be made without these regions of the CNS. The requirements of tissue users will influence the manner in which the brain is dissected, processed, examined, and stored. Each brain bank has its own set of dissection protocols reflecting the disorders collected, the pathological protocols followed and research users' requirements. Typically, one half of the fresh brain is divided sagitally: one half is frozen for biochemistry and molecular genetic studies and the other half is fixed in formalin for histology. Various methods may be used to freeze the brain tissue (snap freezing in liquid nitrogen, cryoprotection and contact freezing with a brass plate at -70°C) depending on local needs and resources.
In addition to brain tissue, cerebrospinal fluid is often routinely taken postmortem and frozen for biochemical studies. In some disorders additional tissues may be taken such as peripheral nerves and muscles in motor neurone disease. In infections of the CNS, such as HIV, it may be informative to identify pathology and determine viral load and strain in multiple organs; in such cases a few grams of tissue from the organs of interest may be sufficient for biochemical and molecular genetic studies. Frozen tissues may be routinely stored for several years in -70°C freezers. With invaluable material it is essential to have constant monitoring of the freezers and back-up facilities to cope with occasional power and mechanical failures. care and users need to be informed of any special safety precautions that they should take. A reliable courier should be used where transport is over either short or long distances and a record of every brain tissue sample distributed must be made. Once a year users of tissue are asked to provide information on the use of tissue provided by the brain bank and copies of any publications making use of this tissue.
Databases

Organisation
It is important that the staff working for the brain bank are available at all hours of the day and night, during the working week and at weekends and bank holidays. Although postmortem examinations may be carried out during office hours, the majority of deaths occur outside these times, staff need to be available to speak to relatives, carers, nursing home staff, medical staff, and funeral directors in order to coordinate the brain tissue donation. In addition, staff need to be available at all times to deal with freezer failure. In practice, a rota operates in most brain banks where the designated individual on call carries a radio pager or mobile telephone. Ethical issues The retention of tissue at necropsy for research purposes other than to establish the cause of death is governed by the Human Tissue Act (1961). Consent for the removal of tissue for educational purposes or medical research is usually given by the donor or the next of kin, or when there are no relatives by the designated officer of the hospital where the patient has been cared for. The donation of human tissue after death should be unconditional and involve no inducement or payment. Brain banks act as stewards in the sense that they have responsibilities and obligations associated with ownership but without the rights associated with property. These duties include: the responsible use of data-for example, conforming to the Data Protection Act (1984), access to ethically approved research, and the responsible and respectful handling of data and tissue.
Brain bank audit and review The funding of brain banks is regularly reviewed. The initial grant to establish a brain bank is made on the basis of peer review and is dependent on the quality of the neuroscience it underpins and reflects the strategic aims of the funding agency. Audit of the work of the brain bank includes the quality of clinical information, recruitment of cases, neuropathological assessment, distribution to users, and the contribution to basic and applied neuroscience research as demonstrated in publications.
Brain banking in Europe in the decade of the brain Europe has an unrivalled reputation in brain research and it is no surprise that there are more brain banks in Europe than in any other continent. Significant advances in our understanding of psychiatric and neurological disorders has come about by the systematic collection of clinically and neuropathologically well characterised tissue. The coordination of brain banking activity in Europe is being promoted by a Concerted Action of the European Community. This network of brain banks has led to the establishment of common neuropathological criteria for the diagnosis of many psychiatric and neurological disorders.'0 More recently, an American Brain Banking Network has been established which will, in time, accommodate the databases of the member banks.29 These European and American networks will enable more efficient collection of common disorders and make more efficient the coordination of the collection of tissue from rare disorders.
